Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
About Us
News and Events
My HPRA:
Login
Register
About Us
Our Mission, Vision and Values
What We Regulate and How We Regulate
Our Strategic Plan 2021 – 2025
Contact Us
Our Structure
Patient Forum
Publications & Forms
Standards of Service
Privacy and Data Protection
Information and transparency
Consultations
Quality Management
Recruitment
Report an Issue
Legislation
Extranets
News and Events
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
HPRA hosts information evening for healthcare professionals on biosimilar medicines
News Category:
Regulatory news
Date:
03/11/2017
The HPRA recently hosted a successful information evening for healthcare professionals to outline how biosimilar medicines are approved for use in patients.
Approximately 60 attendees were present to hear a range of presentations from HPRA staff members and from Dr. Anthony O’Connor who presented from the physician perspective.
The topics covered by the HPRA team included:
- An overview of biological and biosimilar medicines;
- Quality and non-clinical data requirements for biosimilars;
- Clinical data requirements for biosimilars;
- Pharmacovigilance;
- International trends and Interchangeability.
The HPRA slides are now available to
view and download
from our website.
The event concluded with an interactive Q&A session which incorporated a varied range of queries from attendees.
« Back
Date Printed: 26/04/2024